# EF5 to Evaluate Tumor Hypoxia in Patients With High-Grade Soft Tissue Sarcoma or Mouth Cancer

> **NCT00896961** · NA · TERMINATED · sponsor: **National Cancer Institute (NCI)** · enrollment: 120 (actual)

## Conditions studied

- Stage I Adult Soft Tissue Sarcoma
- Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity
- Stage II Adult Soft Tissue Sarcoma
- Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity
- Stage III Adult Soft Tissue Sarcoma
- Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity

## Interventions

- **DRUG:** EF5
- **OTHER:** diagnostic laboratory biomarker analysis
- **OTHER:** pharmacological study

## Key facts

- **NCT ID:** NCT00896961
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2001-08
- **Primary completion:** 2007-09
- **Final completion:** —
- **Target enrollment:** 120 (ACTUAL)
- **Why stopped:** Administratively complete.
- **Last updated:** 2013-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00896961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00896961, "EF5 to Evaluate Tumor Hypoxia in Patients With High-Grade Soft Tissue Sarcoma or Mouth Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00896961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*